Articles

AbbVie announces the submission of regulatory filings for risankizumab to the FDA and EMA seeking approval for the drug as a treatment for psoriatic arthritis.

Risankizumab Submitted for Regulatory Approval to FDA, EMA for Psoriatic Arthritis  

Safety profiles remain consistent longer-term but cost and accessibility are major challenges for biologics aimed at treating psoriasis. 

IL Inhibitors and TYK2 Blocker Near Approval 

Ixekizumab demonstrated long-term efficacy in treating psoriasis and psoriatic arthritis across five years, according to data presented by Eli Lilly at the 29th annual European Academy of Dermatology and Venereology (EADV) Congress.

Ixekizumab demonstrates long-term efficacy 

The U.S. FDA has approved to expand the indication for golimumab (SIMPONI ARIA, Janssen Pharmaceutical Companies of Johnson & Johnson) to include it was a treatment for active psoriatic arthritis (PsA) in pediatric patients 2 years and older.

FDA expands golimumab indication 

Guselkumab becomes the first IL-23 inhibitor approved for treatment of psoriatic arthritis by the U.S. Food and Drug Administration (FDA) following positive phase 3 results from two trials investigating the safety and efficacy of the drug.

FDA approves guselkumab for psoriatic arthritis

The U.S. Food and Drug Administration has approved Mylan and Fujifilm Kyowa Kirin Biologics’ adalimumab-fkjp as a biosimilar to AbbVie’s adalimumab for a variety of inflammatory disease including plaque psoriasis and psoriatic arthritis.

Psoriasis biosimilar approved by FDA

AbbVie announces they have filed applications with the U.S. FDA and EMA for the approval of the JAK inhibitor upadacitinib for the treatment of adult active psoriatic arthritis.

AbbVie seeks approval of upadacitinib in U.S., Europe for psoriatic arthritis

A recent study shows promising results for using ultrasound to examine hand tendon and joint inflammation in psoriatic arthritis patients.

Ultrasound lends a hand in assessing inflammation in psoriatic arthritis

Slideshows

This slideshow breaks down important considerations to keep in mind when evaluating psoriasis patient for psoriatic arthritis.

Screening psoriasis patients for psoriatic arthritis

A recent study discovered that body mass index (BMI) and age of disease onset may play a part in the development of hypertension in psoriatic arthritis and psoriasis. Read what researchers found in this article.